Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/18181
Title: | Management of the Cardiorenal Syndrome in Decompensated Heart Failure | Authors: | VERBRUGGE, Frederik GRIETEN, Lars MULLENS, Wilfried |
Issue Date: | 2014 | Publisher: | KARGER | Source: | CARDIORENAL MEDICINE, 4 (3-4), p. 176-188 | Abstract: | Background: The management of the cardiorenal syndrome (CRS) in decompensated heart failure (HF) is challenging, with high-quality evidence lacking. Summary: The pathophysiology of CRS in decompensated HF is complex, with glomerular filtration rate (GFR) and urine output representing different aspects of kidney function. GFR depends on structural factors (number of functional nephrons and integrity of the glomerular membrane) versus hemodynamic alterations (volume status, renal perfusion, arterial blood pressure, central venous pressure or intra-abdominal pressure) and neurohumoral activation. In contrast, urine output and volume homeostasis are mainly a function of the renal tubules. Treatment of CRS in decompensated HF patients should be individualized based on the underlying pathophysiological processes. Key Messages: Congestion, defined as elevated cardiac filling pressures, is not a surrogate for volume overload. Transient decreases in GFR might be accepted during decongestion, but hypotension must be avoided. Paracentesis and compression therapy are essential to remove fluid overload from third spaces. Increasing the effective circulatory volume improves renal function when cardiac output is depressed. As mechanical support is invasive and inotropes are related to increased mortality, afterload reduction through vasodilator therapy remains the preferred strategy in patients who are normo- or hypertensive. Specific therapies to augment renal perfusion (rolofylline, dopamine or nesiritide) have rendered disappointing results, but recently, serelaxin has been shown to improve renal function, even with a trend towards reduced all-cause mortality in selected patients. Diuretic resistance is associated with worse outcomes, independent of the underlying GFR. Combinational diuretic therapy, with ultrafiltration as a bail-out strategy, is indicated in case of diuretic resistance. | Notes: | [Verbrugge, Frederik Hendrik; Grieten, Lars; Mullens, Wilfried] Ziekenhuis Oost Limburg, Dept Cardiol, BE-3600 Genk, Belgium. [Verbrugge, Frederik Hendrik] Hasselt Univ, Fac Med & Life Sci, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium. [Grieten, Lars; Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Diepenbeek, Belgium. | Keywords: | Cardiorenal syndrome; Congestion; Diuretics; Heart failure; Sodium; Ultrafiltration;cardiorenal syndrome; congestion; diuretics; heart failure; sodium; ultrafiltration | Document URI: | http://hdl.handle.net/1942/18181 | ISSN: | 1664-3828 | e-ISSN: | 1664-5502 | DOI: | 10.1159/000366168 | ISI #: | 000346886700005 | Rights: | © 2014 S. Karger AG, Basel | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2016 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
366168.pdf Restricted Access | 1.52 MB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
29
checked on Apr 30, 2024
Page view(s)
246
checked on Jul 22, 2022
Download(s)
260
checked on Jul 22, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.